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Abstract
Background: Few studies have examined whether risk adjustment is evenly applicable to hospitals with various 
characteristics and case-mix. In this study, we applied a generic prediction model to nationwide discharge data from 
hospitals with various characteristics.
Method: We used standardized data of 1,878,767 discharged patients provided by 469 hospitals from July 1 to October 
31, 2006. We generated and validated a case-mix in-hospital mortality prediction model using 50/50 split sample 
validation. We classified hospitals into two groups based on c-index value (hospitals with c-index ≥ 0.8; hospitals with 
c-index < 0.8) and examined differences in their characteristics.
Results: The model demonstrated excellent discrimination as indicated by the high average c-index and small 
standard deviation (c-index = 0.88 ± 0.04). Expected mortality rate of each hospital was highly correlated with 
observed mortality rate (r = 0.693, p < 0.001). Among the studied hospitals, 446 (95%) had a c-index of ≥0.8 and were 
classified as the higher c-index group. A significantly higher proportion of hospitals in the lower c-index group were 
specialized hospitals and hospitals with convalescent wards.
Conclusion: The model fits well to a group of hospitals with a wide variety of acute care events, though model fit is less 
satisfactory for specialized hospitals and those with convalescent wards. Further sophistication of the generic 
prediction model would be recommended to obtain optimal indices to region specific conditions.
Background
Initiatives to measure healthcare quality attract serious
attention from policy-makers and consumers who believe
that such measurements can drive improvements in the
quality of the service [1]. Recent enthusiasm for outcome
evaluation such as in-hospital mortality, however, has
been challenged because of the difficulties of ensuring
adequate risk adjustment for different patient popula-
tions, an indispensable factor for fairly evaluating health-
care performance [2]. Owing to the clear definition of
outcome and available knowledge on influential patient
conditions, disease-specific risk adjustment models have
been developed in several specialties, including cardio-
vascular diseases, and have been available for various
quality improvement studies [3-6]. However, a risk
adjustment model for a more generic use of outcome
evaluation has not been fully developed [7]. In our previ-
ous study, we proposed and tested a generic risk predic-
tion model to predict the risk of in-hospital mortality,
with variables easily obtainable from large electronic
administrative databases [8]. Our model showed excellent
precision and calibration compared to other risk adjust-
ment models [9-12].
However, the dataset used in the previous study was
derived mainly from large university-affiliated teaching
hospitals, which may compromise the ability to general-
ize results to a broader array of hospitals. Since the calcu-
lation of risk-adjusted in-hospital mortality is often
conducted for benchmarking purposes, whether the risk
adjustment model is applicable to hospitals with varying
characteristics and case-mix must be clarified. To date,
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few studies have examined whether case-mix risk adjust-
ment can be evenly applied such hospitals. In this study,
we applied a generic case-mix-based risk adjustment
model for in-hospital mortality prediction to hospitals
with varying characteristics, and evaluated its perfor-
mance for benchmarking risk-adjusted hospital mortality
using a nationwide database of discharge cases.
Methods
Data source
We used an electronic, standardized dataset of dis-
charged patients provided by 469 hospitals that partici-
pated in a Japanese patient classification system and
related evaluation scheme from July 1 to October 31,
2006. The patient classification system, or Diagnosis Pro-
cedure Combination (DPC), includes information for up
to two major diagnoses and up to six co-existing diagno-
ses. The 2008 version of the DPC system includes 18
major diagnostic categories (MDC) and 506 disease sub-
categories coded in ICD10. For analytic purposes, we re-
categorized the 18 MDCs into 10 MDCs based on mor-
tality rates. The dataset also includes additional informa-
tion such as patient demographics, uses and types of
surgical procedures, emergency/elective hospitalization,
length of stay, and discharge status (including in-hospital
death) [13-15]. Records for 1,878,767 discharge cases
were available for the following analysis. Cases were ran-
domly assigned into two subsets with an approximate 50/
50 split: one for model development and the other for val-
idation tests. The obtained model development dataset
included 939,409 records and the validation dataset
included 939,358 records. Because of the anonymous
nature of the data, the requirement for informed consent
was waived. Study approval was obtained from the insti-
tutional review board of the hospital with which the last
author was affiliated.
Model building and validation
We started with the mortality prediction model used in
our previous study [8]. The model includes age, gender,
use of an ambulance at admission, admission status
(emergency/elective), MDC of the primary diagnosis, and
comorbidity. Based on Quan's methodology [9], the ICD-
10 code of each co-existing diagnosis was converted into
a Charlson Comorbidity Index score. We classified scores
into five categories: 0, 1-2, 3-6, 7-12, and 13 and over. We
further modified our former model by including "admis-
sion purpose." In the previous study, we found that the
mortality risk of patients with cardiovascular diseases
t e n d e d  t o  b e  u n d e r e s t i m a t e d  b e c a u s e  t h i s  g r o u p  o f
patients included those hospitalized only for post-opera-
tive evaluation. Thus, including admission purpose
should improve the precision of low-risk prediction. We
also included Eastern Cooperative Oncology Group per-
formance status (grade 0, fully active; grade 4, completely
disabled) [16] and Fletcher-Hugh-Jones classification of
respiratory status (class 1, patient's breathing is similar to
others of the same sex and age; class 5, patient is breath-
less when talking or undressing, or is unable to leave the
house due to breathlessness) [17]. These parameters were
included because the mortality risk of patients with can-
cer and chronic pulmonary diseases tended to be overes-
timated, and inclusion of these additional scores should
improve predictive precision for such patients. Given that
Fletcher-Hugh-Jones classification and performance sta-
tus scores were required only for those with chronic pul-
monary diseases and cancer, missing observations were
treated as null values. A multivariate logistic regression
analysis including variables mentioned above was per-
formed to predict in-hospital mortality using the devel-
opment dataset. The tests of model performance and
fitness were conducted using the test dataset. Accuracy of
the prediction models was determined with the c-index
[18]. We assessed the ability of the model to accurately
predict mortality across all ranges of risk by comparing
predicted and observed mortality rates in predicted mor-
tality risk deciles.
Comparison of hospital performance
We excluded from analysis one hospital that had a mor-
tality rate of zero because the c-index could not be calcu-
lated. Given that a c-index of 0.8 to 0.9 is considered
excellent [19], we divided hospitals into two groups by
setting a c-index of 0.8 as the cut-off point. We then
examined differences in characteristics between the two
groups of hospitals, including size, number of admissions,
crude and predicted mortality, and distribution of patient
demographics and diseases using Fisher's exact test and
the t-test as appropriate. Hospitals for which the sole
MDC category accounted for more than half of all hospi-
talized cases were considered "specialized hospitals." All
statistical tests were 2-tailed and the significance level
was set at p < 0.05.
Standardized mortality ratios (SMRs) were obtained by
calculating the ratio of observed mortality to expected
mortality estimated by the model. Standardized mortality
rate was obtained by multiplying SMRs and the average
in-hospital mortality rate for all hospitals. All analyses
were conducted with SPSS version 15.0J (SPSS Japan,
Inc).
Results
Table 1 shows patient characteristics in the development
and validation datasets. Among the 939,409 patientsMiyata et al. BMC Health Services Research 2010, 10:130
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Table 1: Patients characteristics in development dataset (n = 939,409) and validation dataset (n = 939358)
Development Dataset Validation Dataset
N% N %
Major Diagnostic Category Digestive system 194,257 20.7 193,857 20.6
Respiratory System 100,591 10.7 101,001 10.8
Blood and Blood Forming Organs and 
Immunological Disorders
22,741 2.4 23,009 2.4
Kidney 73,240 7.8 73,353 7.8
Nervous System 65,096 6.9 64,619 6.9
Circulatory System 91,892 9.8 92,188 9.8
Female, Breast 82,732 8.8 82,696 8.8
Endocrine 31,528 3.4 31,488 3.4
Skin, Ear, Eye, Pediatric and Newborn 139,642 14.7 139,614 14.9
Musculoskeletal, injuries and others 137,690 14.7 137,533 14.6
Sex Male 497,564 53.0 307,974 32.8
Age (years) under50 306,473 32.6 134,255 14.3
50-59 134,905 14.4 185,643 19.8
60-69 186,102 19.8 207,560 22.1
70-79 208,171 22.2 89,130 9.5
80-89 88,922 9.5 14,796 1.6
90 and over 14,836 1.6 307,974 32.8
Total score of Charlson Index score0 652,986 69.5 651,578 69.4
score1,2 209,063 22.3 209,543 22.3
score3-6 53,781 5.7 53,974 5.7
score7-12 17,645 1.9 18,202 1.9
score13- 5,934 0.6 6,061 0.6
Admission Status Status emergency 397,650 42.3 397,802 42.3
Use of an ambulance 116,987 12.5 116,988 12.5
Hospitalization for examination 62,673 6.7 63,012 6.7
Planned short-term admission 44,434 4.7 44,494 4.7
Performance Status grade0, grade1, or missing 921,721 98.1 921,533 98.1
grade2 7,544 0.8 7,724 0.8
grade3 5,103 0.5 5,103 0.5
grade4 5,041 0.5 4,998 0.5
Fletcher Hugh-Jones Classification class1, class2, or missing 912,266 97.1 911,891 97.1
class3, class4 16,082 1.7 16,306 1.7
class5 110,61 1.2 11,161 1.2
In-hospital Mortality 34,636 3.7 34,866 3.7
C-index 0.882 0.882Miyata et al. BMC Health Services Research 2010, 10:130
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(male, 53.0%; age under 50 years at admission, 32.6%; age
of 90 years or older, 1.6%) in the development dataset, the
MDC with the highest proportion was the "digestive sys-
tem (20.7%)," followed by "skin, ear , eye, pediatric, and
newborn (14.7%)," "musculoskeletal, injuries, and others
(14.6%)," "respiratory system (10.7%)," "circulatory system
(9.8%)," "female, breast (8.8%)," "kidney (7.8%)," "nervous
system (6.9%)," "endocrine (3.4%)," and "blood, blood
forming organs, and immunological disorders (2.4%)."
The majority of patients (69.5%) had a total score of 0 for
the Charlson Comorbidity Index, and only 2.5% of
patients had a score higher than 6. With regard to admis-
sion status, 42.3% had emergency status, 12.5% used an
ambulance, 6.7% stayed in the hospital for examination,
and 4.7% planned short-term admissions. For cancer per-
formance status, almost all patients were grade 0, grade 1,
or missing (98.1%), while only 1.8% of patients were grade
2 or higher. For the Fletcher Hugh-Jones classification,
almost all patients were class 1, class 2, or missing
(97.1%), while only 2.9% of patients were class 3 or higher.
Table 2 shows the in-hospital mortality prediction
model applied to the development dataset. Using the
"musculoskeletal, injuries, and others" MDC as a refer-
ence, MDCs for "endocrine" and "skin, ear, eye, pediatric,
and newborn," showed a significantly lower odds ratio for
in-hospital deaths compared to other MDCs. Older age,
male gender, use of ambulance at admission, and emer-
gency admission status showed a significantly higher
odds ratio. Hospitalization for examination and planned
short-term admission showed a significantly lower odds
ratio. As scores increased for the Charlson Comorbidity
Index, performance status, and Fletcher-Hugh-Jones
classification, the odds ratio exhibited a linearly increas-
ing trend.
The risk prediction model exhibited a c-index of 0.882
for both development and validation datasets. Predicted
and observed deaths in the validation dataset are shown
in Figure 1 by risk decile. Expected mortality was lower
than observed mortality in higher deciles, whereas the
reverse was observed in lower deciles.
Table 3 summarizes major characteristics of the 468
hospitals (mean ± standard deviation of c-index for each
hospital, 0.88 ± 0.04). Among these hospitals, 446 were
allocated to the higher c-index group (average c-index;
0.882, 95%CI; 0.878-0.885), and 22 to the lower c-index
group (average c-index; 0.772, 95%CI; 0.757-0.786). The
higher c-index group had a significantly higher number of
admissions, hospital mortality rate, and standardized
mortality rate. Hospitals in the lower c-index group were
significantly more likely to be specialized hospitals, hos-
pitals with convalescent wards, and private hospitals. Fig-
ure 2 plots expected and observed mortality by higher
and lower c-index groups (expected mortality rates repre-
sent average predicted risk in each hospital). The lower c-
index group tended to be positioned off-diagonal in the
plot, but no systematic trend of overestimation or under-
estimation was found between the two groups. Expected
mortality in each hospital was highly correlated with
observed mortality (total, r = 0.693, p < 0.001). The corre-
lation between expected and observed mortality in the
higher c-index group (r = 0.702, p < 0.001) was higher
compared to that of the lower c-index group (r = 0.663, p
< 0.01). The average observed mortality to expected mor-
tality (OE) ratio by risk decile for hospitals is shown in
Table 4. A comparison of the standardized and raw mor-
tality rate quartiles is displayed in Table 5. After risk
adjustment, 62% percent of hospitals (n = 290) were cate-
gorized in a different quartile.
Discussion
In this study, we developed a modified case-mix-based
risk adjustment model for in-hospital mortality using
administrative data, and tested its performance in various
types of hospitals. The model demonstrated excellent dis-
crimination as indicated by the high average c-index, and
was applicable to the majority of hospitals in our sample
set taken from a large hospital discharge database. How-
ever, our finding that a few hospitals had a lower c-index
warrants further discussion.
The hospitals with a lower c-index were characterized
by a case-mix predominantly involving circulatory and
nervous system disorders, and older patients with higher
mortality. These characteristics indicate that hospitals
with a lower c-index were those that provided a combina-
tion of acute and long-term care. As is often reported,
Japanese hospitals, especially small/middle-sized private
hospitals, are not well differentiated with respect to pro-
vision of acute and long-term care [20]. The hospitals
with a lower c-index provided both acute and long-term
care specifically to stroke patients. Although the Japanese
patient classification system includes the majority of
acute-care hospitals, and our dataset should cover a large
share of these hospitals, the recent expansion of the sys-
tem to include a wider range of hospitals has led to
increased heterogeneity in the functions of participating
hospitals. Our results may suggest that the proposed risk
prediction model does not apply as well to mixed-care
hospitals, and should be selectively applied to general
hospitals that provide acute care.
Our model demonstrated excellent discrimination
without the need for detailed clinical data. As discussed
in a previous study [8], our model's high predictive preci-
sion was made possible by including patient demograph-
ics and admission status, further combined with MDCs
and the Charlson Comorbidity Index. All variables are
easily accessible from administrative data properly codedMiyata et al. BMC Health Services Research 2010, 10:130
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Table 2: Detail of mortality prediction model of development dataset (n = 939,409)
odds ratio 95% CI
lower upper
Major Diagnostic Digestive system 1.81 1.73 1.89
Category Respiratory System 1.56 1.48 1.65
Blood and Blood Forming Organs and 
Immunological Disorders
5.49 5.16 5.84
Kidney 1.40 1.32 1.49
Nervous System 1.80 1.71 1.89
Circulatory System 1.76 1.67 1.85
Female, Breast 1.16 1.07 1.27
E n d o c r i n e 0 . 6 20 . 5 60 . 6 9
Skin, Ear, Eye, Pediatric and Newborn 0.39 0.35 0.42
Musculoskeletal, injuries and others 1.00 (reference)
S e x M a l e 1 . 2 31 . 2 01 . 2 6
Age (years) under50, 50-59, 60-69,70-79, 80-89, 90 and 
over
1.45 1.44 1.46
Total score of Charlson 
Index
score0 1.00 (reference)
score1,2 1.23 1.20 1.27
score3-6 3.17 3.05 3.29
s c o r e 7 - 1 2 5 . 9 25 . 6 16 . 2 6
score13- 10.30 9.51 11.14
Admission Status Status emergency 2.80 2.71 2.89
Use of an ambulance 2.39 2.33 2.46
Hospitalization for examination 0.11 0.09 0.13
Planned short-term admission 0.25 0.23 0.28
Performance Status grade0, grade1, or missing 1.00 (reference)
grade2 3.00 2.79 3.23
grade3 7.29 6.81 7.81
grade4 23.98 22.35 25.73
Fletcher Hugh-Jones 
Classification
class1, class2, or missing 1.00 (reference)
class3, class4 1.47 1.38 1.57
class5 5.26 4.97 5.57Miyata et al. BMC Health Services Research 2010, 10:130
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with internationally standardized disease codes such as
ICD-10, and allows for excellent model performance. Our
model framework may be applicable and useful in other
countries as well.
Public disclosure of hospital performance (e.g., hospi-
tal-standardized mortality rate) is considered to provide
informed choice to consumers/patients, provide a bench-
mark for hospital management, and enhance efficiency of
the health care system by stressing competition over
quality. Proper risk adjustment then becomes crucial for
providing unbiased information on the quality of hospital
performance. As we have demonstrated, risk adjustment
had a marked impact on hospital ranking, since a larger
share of hospitals shifted to a different quartile of hospital
mortality rate after adjustment. These results suggest that
our model can be used for benchmarking hospital-stan-
dardized mortality rate with fair risk adjustment among
acute-care hospitals.
A potential limitation of our study worth noting is the
quality of diagnosis coding in the database. We relied on
original data submitted by participating hospitals, simply
because the same information is used in actual billing
statements for claim reimbursement. Our preliminary
analysis did not identify serious flaws in the quality of
ICD10 codes, although the quality of coding and how it
affects the precision of risk prediction may be an impor-
t a n t  i s s u e  t o  b e  a d d r e s s e d  i n  f u t u r e  s t u d i e s .  R e g i o n a l
applicability, however, may be more of a concern for the
risk adjustment framework. A recent international com-
parative study [21] demonstrated that while cross-
national application of a formula can achieve high predic-
tive accuracy, the level of accuracy varied across coun-
tries [8,21]. This may be partly because disease
distribution and burden are different between countries
with different health care systems. Thus, it may be prefer-
able for investigators to develop "optimal" indices for
Figure 1 Predicted and observed mortality by risk decile (n = 939,358). The horizontal axis shows ten predicted mortality ranges. The total num-
ber of patients in these ranges is shown in the lower columns. The observed mortality rate with its associated 95% confidence interval is shown by 
the dark square. The predicted mortality rate is indicated by bar graphs. The c-index of the model is 0.882.
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All Hospitals c-index ->0.8 c-index < 0.8 P value
N = 468 N = 446 N = 22
Mean SD Mean SD Mean SD
C-index 0.88 0.04 0.88 0.03 0.77 0.03 <0.001
Number of 
admission
4011.5 2539.4 4128.9 2528.6 1631.7 1297.3 <0.001
Hospital mortality 
rate
4.0% 1.5% 4.0% 1.4% 5.0% 2.9% 0.001
Average predicted 
risk
4.0% 1.3% 4.0% 1.3% 4.4% 1.9% 0.251
Standardized 
mortality rate
3.8% 1.3% 3.7% 1.1% 4.7% 3.4% 0.001
Major Diagnostic 
Category
Digestive system 21.2% 8.5% 21.6% 8.2% 14.7% 11.7% <0.001
Respiratory System 11.0% 4.5% 11.1% 4.4% 9.5% 6.7% 0.106
Blood and Blood Forming Organs 
and Immunological Disorders
2.0% 1.6% 2.1% 1.6% 1.1% 1.2% 0.007
Kidney 7.9% 5.5% 7.8% 4.8% 8.9% 13.4% 0.351
Nervous System 7.8% 8.4% 7.2% 6.6% 20.1% 22.2% <0.001
Circulatory System 10.0% 9.2% 9.8% 8.3% 14.1% 20.2% 0.033
Female, Breast 7.5% 5.9% 7.7% 5.8% 2.4% 6.4% <0.001
Endocrine 3.3% 1.7% 3.4% 1.7% 2.9% 2.0% 0.224
Skin, Ear, Eye, Pediatric and 
Newborn
13.6% 5.9% 13.9% 5.8% 6.9% 5.0% <0.001
Musculoskeletal, injuries and 
others
15.6% 8.7% 15.5% 8.3% 19.2% 15.4% 0.052
Sex Male 52.8% 4.8% 52.8% 4.7% 54.6% 6.8% 0.072
Age (years) under50 30.4% 9.9% 30.9% 9.6% 19.5% 9.5% <0.001
50-59 13.8% 2.8% 13.8% 2.7% 13.9% 3.7% 0.878
60-69 19.4% 3.6% 19.4% 3.5% 20.1% 5.1% 0.346
70-79 23.0% 4.3% 22.8% 4.2% 27.0% 4.4% <0.001
80-89 11.3% 4.6% 11.0% 4.3% 16.2% 7.1% <0.001
90- 2.1% 1.6% 2.1% 1.5% 3.4% 2.5% <0.001
Admission Status Status emergency 47.0% 15.6% 46.7% 15.2% 51.6% 22.0% 0.155
Use of an ambulance 13.6% 7.3% 13.4% 6.8% 19.3% 12.6% <0.001
Hospitalization for examination 4.0% 5.8% 4.1% 5.9% 3.0% 5.2% 0.374
Planned short-term admission 6.8% 5.9% 6.6% 4.7% 11.0% 16.9% 0.001
N% N % N % P  v a l u e
Public hospital** 130 27.8 128 28.7% 2 9.1% 0.025
University hospital** 77 16.5% 76 17.0% 1 4.5% 0.079
Special hospital** 25 5.3% 18 4.0% 7 31.8% <0.001
Have convalescent 
wards**
43 10.0% 38 9.3% 5 26.3% 0.025
*One hospital (mortality rate = 0%) was excluded from this analysis
**percentage of total hospitalsMiyata et al. BMC Health Services Research 2010, 10:130
http://www.biomedcentral.com/1472-6963/10/130
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their own data-specific and condition-specific model
coefficients.
Physicians and hospitals will strongly oppose public
reporting if risk-adjusted outcomes are not reflective of
provider-specific performance [22]. Enhanced validity
and reliability of standardized mortality rates and other
risk-adjusted outcomes may be essential not only for
benchmarking, but also for public reporting. Utilizing
process measures in conjunction with risk-adjusted out-
comes may also be used for quality improvement, as
some research has documented an association between
higher adherence to care guidelines and better outcomes
of patients who receive that care [23,24]. However, other
research has suggested that hospital performance mea-
sures predict small differences in hospital risk-adjusted
mortality rates [25]. Further efforts are needed to develop
performance measures that are tightly linked to patient
outcomes. We also note that in-hospital mortality reflects
just one aspect of hospital performance. In order to prop-
erly reflect patient values, it may be necessary to assess
hospital performance using other factors as well, such as
potentially avoidable adverse events (e.g., readmission
and complications) [26].
Conclusion
The risk model developed in this study exhibited a good
degree of predictive accuracy for benchmarking hospital
mortality with variables easily accessible from adminis-
trative data. The model fits better to and can be applied
selectively to benchmarking general acute care hospitals.
However, model fit is less satisfactory for specialized hos-
pitals and those with convalescent wards. Further sophis-
tication of the generic prediction model would be
recommended to obtain optimal indices to region spe-
cific conditions.
Figure 2 Expected versus observed hospital mortality rate (n = 
468*). Each dot represents data from one hospital (r = 0.693, p < 0.001). 
Expected mortality rates represent average predicted risk in each hos-
pital. *One hospital (mortality rate = 0%) was excluded from this anal-
ysis.
Table 4: Hospital average OE ratio** by risk deciles (n = 468)
Hospital average 
preoperative risk
Number of hospitals Average OE ratio 95% CI
lower upper
Under 2.0% 21 1.15 0.68 1.62
2.0-2.5% 34 1.11 1.01 1.21
2.5-3.0% 61 1.05 0.96 1.14
3.0-3.5% 59 1.11 1.03 1.19
3.5-4.0% 67 1.02 0.96 1.09
4.0-4.5% 68 1.03 0.96 1.10
4.5-5.0% 49 0.95 0.89 1.00
5.0-5.5% 44 0.96 0.88 1.03
5.5-6.0% 33 0.88 0.82 0.95
6.0% and over 32 0.89 0.80 0.98
**OE ratios means "Observed mortality/Expected mortality ratio"Miyata et al. BMC Health Services Research 2010, 10:130
http://www.biomedcentral.com/1472-6963/10/130
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